Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Here’s a Company That’s Behind the Wheel Driving E-Commerce Growth

Logiq Inc. ( NEO.LGIQ , OTCMKTS: LGIQ , Forum) an E-commerce company that’s quickly transforming how companies operate and compete for growth while boasting multi-faceted revenue sources. When Stockhouse last caught up with Logiq back in late August , ...
Dave Jackson | November 12, 2021 |

How Investors Can Jump on the ESG Train

Back in August , we introduced our Stockhouse investor audience to a very different, and very profitable, kind of ESG company that’s been a market leader in Environmental Services – Vertex Resource Group Ltd. ( TSX-V.VTX , Forum ). In this exclusive ...
Dave Jackson | November 4, 2021 |

Why There is Still a Dire Need for COVID-19 Testing

(Click image to play video) While the tide has turned in many countries in battle against the COVID-19, the global pandemic is far from over in countries like India, for example. Thus, the need for quick, reliable COVID at-home testing is still existential. T...
Dave Jackson | June 7, 2021 |

Fact: Cybersecurity is One of the World’s Fastest Growing Investment Opportunities

(Click image to play video) Cybersecurity attacks continue to be an existential threat to businesses and organizations – particularly as the move to continue to work from home in the wake of COVID-19 becomes more prevalent – and shows no signs of slowing down. I...
Dave Jackson | May 18, 2021 |

This Company is Already Generating Revenue in Canada’s New Data Frontier

(Image via SkyChain Technologies Inc.) Considered the future of enterprise data processing, Edge computing promises major leaps in data processing, as it allows internet consumers to use more connected applications and devices with minimal latency / lag time and networ...
Jonathon Brown | March 9, 2021 |

The Plant-Based / Psychedelics Hybrid Co. “Positioned For Growth”

(Click image to play video) M eet the Company and its CEO that’s positioning itself to be the premier cannabis commercialization extractor and manufacturing partner for functional psychedelic mushroom companies. Based on extensive extractio...
Dave Jackson | November 2, 2020 |

FDA Grants Ampio Pharma Approval to Begin Phase 1 Trial in COVID-19 Patients

Ampio Pharmaceuticals' shares traded higher after the company reported that the FDA cleared the firm to proceed with human trials of its Investigative New Drug application for intravenous AmpionTM for treatment in COVID-19 affected patients on supplemental oxygen. ...
Streetwise Reports | June 22, 2020 |

Growth Is Crushing Value Right Now, but Take a Long-Term Horizon

Investors are betting on growth stocks over value stocks by a wider spread right now than at any other time since at least 1990, including during the tech bubble. The ratio between the Russell 1000 Growth Index and Russell 1000 Value Index reached a series high of 1....
Frank Holmes | May 27, 2020 |

A New Solution for the Multibillion-Dollar Bladder Cancer Problem

Bladder cancer is the sixth-most prevalent cancer in North America and has a recurrence rate greater than 50%, making it the most expensive cancer to treat. All-in costs in the US are around $4 billion and roughly 80,000 new American cases are reported each year, with 350,000...
Stockhouse Editorial | May 25, 2020 |

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. In a May 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed why the outlook is positive for Daré Bioscience In...
Streetwise Reports | May 21, 2020 |
1 2 3